Member Info for sphinx100

Pumpky it really doesn’t take a lot to look up the facts ,you should try it sometime , From the Mou Product formulations which are covered under the Company's existing patents would continue to be owned outright by the Company, and the Company would retain proportional joint ownership of any new product formulations developed as part of the project. It is envisaged that the Company will provide scientific and technical support for Fruitflow® to BY-HEALTH throughout the collaboration.

Thanks Gixer another great find , reading the translation basically talks about the problems China is facing with regard to cardiovascaler health ,they say there are 290 million Chinese people at risk ,they also give advice on keeping healthy that includes cutting out smoking and cutting down on alcohol ,Fruitflow is mentioned as a natural Asprin . All very encouraging for Pxs ,let’s hope some news soon on China .

And how are you going to fund that !

Thanks for making things a bit clearer , seems the clinical trial will be completed this year 2019 but we know how these timelines can slip , as you say this will not stop the launch of the other products into the Chinese market, let’s hope e get some news soon .

Gixer thanks for that , from all the snippets of information we have it seems to me that the ongoing clinical trial in China must be linked to a Antihypertensive drug , which of course would be huge if launched in China , on the downside drug trials tend to last years rather than months so could be be sometime away yet .

Looks like they are trying to establish a hypertensive drug ! Office: Japan
Application Number: 2018211985 Application Date: 12.11.2018
Publication Number: 2019038844 Publication Date: 14.03.2019
Publication Kind: A
IPC:
A61K 36/81
Applicants: University of Oslo
University of Oslo
Inventors: Dattaroy Asim Kay
Agents: Koichi Aoi
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Ichikawa Satsuki
Priority Data: 61 / 636,813 23.04.2012 US
Title: (EN) Use of tomato extract as an antihypertensive agent and method for producing water-soluble sugar-free tomato extract
Abstract:
(EN)
PROBLEM TO BE SOLVED: To prepare tomato extract as an antihypertensive drug which regulates blood pressure.
The tomato extract comprises a water-soluble, sugar-free tomato extract or an active fraction thereof.

Bella you ask if those numbers include the H&B sales , I think they do ,from the interims “An increase in revenue net of sales rebates from the Company’s Fruitflow®+ Omega-3 business, including Holland & Barrett, the Company’s website www.fruitflowplus.com and Amazon UK, which grew by 36% year on year to £47k in the six months ended 30 September 2018, compared to £34k in the six months ended 30 September 2017.”

Perhaps a pharmaceutcal solution to a Men’s health problem , ‘ from the interims “ with two studies successfully completed, one study currently ongoing at a clinical site and three further planned human studies confirmed by BY-HEALTH. The two completed studies (a human study and an animal study) showed excellent results in use for Fruitflow®.’

Been updated with new women’s health highlighted, they seem to be pushing this angle more now ,perhaps some new research announcements soon

Think you are being a bit over optimistic there ,but then again P.e ratios can be more than 50 on AIM so I wouldn’t rule anything out

Some decent volume today steady rise will do me

Some isa sell/ buys today ,close to end of tax year .

That didn’t work try this https://www.dsm.com/markets/human-nutrition/en-gb/talking-nutrition/dsm-presents-consumer-driven-customized-innovation.html

https://www.dsm.com/markets/human-nutrition/en-gb

Gixer. I think they are saying that Fruitflow is the new concept ,which I’m sure will be in their minds to be a key ingredient in future products

Translated . Dr. Ye of DSM showed us that EPA+DHA can reduce triglyceride levels with a significant dose-effect relationship.

In addition, Dr. Ye also introduced a “tomato concentrate”, FruitFlow®, which causes platelets to activate platelets during the first phase of the agglutination process and keeps the platelets smooth and prevents them from agglutinating in the blood vessels.

We were all waiting for a global company to launch a product ,I suppose they don’t get more global than DSM

Product formulations which are covered under the Company's existing patents would continue to be owned outright by the Company, and the Company would retain proportional joint ownership of any new product formulations developed as part of the project. It is envisaged that the Company will provide scientific and technical support for Fruitflow® to BY-HEALTH throughout the collaboration.

As do I

Maybe one of the HNW investors needed some money back in a hurry , who knows we will never find out unless it’s one of the +3% investors !